Evolent Health Inc. (NYSE:EVH)’s share price was up 3.1% during trading on Tuesday . The stock traded as high as $26.52 and last traded at $26.44, with a volume of 293,449 shares. The stock had previously closed at $25.65.

Several equities analysts recently commented on EVH shares. Canaccord Genuity reissued a “buy” rating and set a $30.00 price target on shares of Evolent Health in a research report on Wednesday, July 13th. Leerink Swann restated a “buy” rating and set a $20.00 price objective on shares of Evolent Health in a report on Monday, May 16th. Zacks Investment Research upgraded Evolent Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th. Jefferies Group started coverage on Evolent Health in a report on Tuesday, July 26th. They set a “buy” rating and a $28.00 price objective on the stock. Finally, FBR & Co lifted their price objective on Evolent Health from $24.00 to $26.00 and gave the stock an “outperform” rating in a report on Friday. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $22.50.

The stock’s market capitalization is $1.13 billion. The firm’s 50 day moving average price is $21.53 and its 200 day moving average price is $14.19.

Evolent Health (NYSE:EVH) last issued its earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.04. During the same period in the previous year, the company earned ($0.95) earnings per share. The firm earned $56.50 million during the quarter, compared to analyst estimates of $51.96 million. The business’s revenue for the quarter was up 443.3% on a year-over-year basis. Analysts predict that Evolent Health Inc. will post ($0.55) earnings per share for the current fiscal year.

An institutional investor recently raised its position in Evolent Health stock. Schroder Investment Management Group boosted its stake in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Evolent Health worth $4,310,000 at the end of the most recent quarter.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.